Le Lézard
Classified in: Business
Subject: DIVIDENDS

Dividend 15 Split Corp. Declares 164th Consecutive Monthly Distribution


TORONTO, ONTARIO--(Marketwired - Nov. 20, 2017) - Dividend 15 Split Corp. declares its 164th consecutive monthly distribution of $0.10000 for each Class A share ($1.20 annually) and $0.04375 for each Preferred share ($0.525 annually). Distributions are payable December 8, 2017 to shareholders on record as at November 30, 2017.

Since inception Class A shareholders have received a total of $19.90 per share and Preferred shareholders have received a total of $7.20 per share inclusive of this distribution, for a combined total of $27.10.

Dividend 15 invests in a high quality portfolio of leading Canadian dividend-yielding stocks as follows: Bank of Montreal, Bank of Nova Scotia, Canadian Imperial Bank of Commerce, Royal Bank of Canada, Toronto-Dominion Bank, National Bank of Canada, CI Financial Corp., BCE Inc., Manulife Financial, Enbridge, Sun Life Financial, TELUS Corporation, Thomson Reuters Corporation, TransAlta Corporation, TransCanada Corporation.

   
Distribution Details  
 
Class A Share (DFN) $0.10000
 
Preferred Share (DFN.PR.A) $0.04375
 
Ex-Dividend Date: November 29, 2017
 
Record Date: November 30, 2017
 
Payable Date: December 8, 2017

These press releases may also interest you

at 22:00
Zetrix Foundation and MY E.G. Services Berhad ("MYEG") signed a Memorandum of Understanding (MoU) with MaiCapital, a licensed virtual asset manager in Hong Kong, to collaborate on the launch of a virtual asset fund or Hong Kong virtual assets...

at 21:38
Grupo Elektra, S.A.B. de C.V. (BMV: ELEKTRA* Latibex: XEKT), Latin America's leading specialty retailer and financial services company, and the largest non-bank provider of...

at 21:30
O2Gold Inc. (NEX: OTGO.H) ("O2Gold" or the "Company") is pleased to announce that it has entered into a share exchange agreement dated March 21, 2024 (the "Agreement") with Quebec Aur Ltd., a private Ontario corporation, (the "Target") and its...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 20:30
Nium, the global leader in real-time cross-border payments, today announced the expansion of its partnership with Thredd, a leading global payments processor, to issue virtual cards in the Asia Pacific (APAC) region.     Nium's virtual card solution...

at 20:05
Mirasol Resources Ltd. (the "Company" or "Mirasol") is pleased to announce the closing of the first tranche of its previously announced non-brokered private placement. The Company issued 3,887,552 Units (the "Units") at a price of $0.60 per Unit...



News published on and distributed by: